Methylglyoxal-mediated growth inhibition in an Escherichia coli cAMP receptor protein mutant.
Under certain growth conditions, some strains of Escherichia coli accumulate toxic levels of methylglyoxal. This report characterizes a strain which synthesizes a mutant cAMP receptor protein in an adenylate cyclase deletion background. When cultured in glucose 6-phosphate minimal medium, this strain (222) was prematurely growth arrested due to methylglyoxal production; growth inhibition did not occur when the strain was grown in glucose minimal medium. A comparison of a variety of enzyme and cofactor levels in the related strains 222 (mutant) and 225 (wild-type) grown on either glucose or glucose 6-phosphate medium was carried out. The only difference found that might explain an increase in methylglyoxal accumulation was an elevated level of phosphofructokinase in strain 222 grown on glucose 6-phosphate. Since this enzyme activity probably limits hexose phosphate metabolism, it is suggested that growth inhibition in strain 222 may be due to increased production of triose phosphate, some of which is converted to methylglyoxal.
D000262:Adenylyl Cyclases / Q000502:physiology; D000447:Aldehydes / Q000494:pharmacology*; D003563:Cyclic CMP / Q000502:physiology; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D009154:Mutation; D011765:Pyruvaldehyde / Q000494:pharmacology*; D011953:Receptors, Cyclic AMP / Q000235:genetics / Q000502:physiology*
D000447:Aldehydes; D011953:Receptors, Cyclic AMP; D003563:Cyclic CMP; D011765:Pyruvaldehyde; D000262:Adenylyl Cyclases